Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
1
×
Tags
antisense oligonucleotide
1
×
benzodiazepines
biogen
biotech
blackstone group
blackstone life sciences
boston
boston blog main
boston top stories
clinical trials
columbia university
david goldstein
depression
epi4k
epilepsy
essential tremor
investing
kiran reddy
life sciences
major depressive disorder
marcio souza
national blog main
national top stories
new york blog main
new york top stories
perimenopausal depression
1
×
praxis precision medicines
ptc therapeutics
startups
steven petrou
third rock ventures
university of melbourne
venture capital
What
aims
backed
1
×
cause
ceo
drugs
epilepsy
1
×
genes
genetic
links
marcio
medicines
mutations
neuro
new
1
×
praxis
precision
research
souza
stop
turn
Language
unset
Current search:
backed
×
photo
×
new
×
" antisense oligonucleotide "
×
" perimenopausal depression "
×
epilepsy
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs